Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
American Journal of Physiology. Renal Physiology|December 28, 2007
Effects of targeted Bcl-2 expression in mitochondria or endoplasmic reticulum on renal tubular cell apoptosisKirti Bhatt, Leping Feng, Navjotsingh Pabla, et al.
American Journal of Physiology. Renal Physiology|July 20, 2006
Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53Jinzhao Wang, Navjotsingh Pabla, Cong-Yi Wang, et al.
Journal of the American Society of Nephrology : JASN|April 17, 2010
PKC-delta promotes renal tubular cell apoptosis associated with proteinuriaXiaoning Li, Navjotsingh Pabla, Qingqing Wei, et al.
The Journal of Clinical Investigation|June 3, 2011
Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancerNavjotsingh Pabla, Guie Dong, Man Jiang, et al.
Journal of the American Society of Nephrology : JASN|January 15, 2015
MicroRNA-687 Induced by Hypoxia-Inducible Factor-1 Targets Phosphatase and Tensin Homolog in Renal Ischemia-Reperfusion InjuryKirti Bhatt, Qingqing Wei, Navjotsingh Pabla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2014
Cisplatin-induced renal injury is independently mediated by OCT2 and p53Jason A Sprowl, Cynthia S Lancaster, Navjotsingh Pabla, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2015
Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functionsNavjotsingh Pabla, Alice A Gibson, Mike Buege, et al.
Cancer Research|February 18, 2017
OCTN1 Is a High-Affinity Carrier of Nucleoside AnaloguesChristina D Drenberg, Alice A Gibson, Stanley B Pounds, et al.
The Journal of Clinical Investigation|December 12, 2017
Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemiaJolieke G van Oosterwijk, Daelynn R Buelow, Christina D Drenberg, et al.
Cancer Research Communications|August 29, 2024
Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow ScreenThomas Drabison, Mike Boeckman, Yan Yang, et al.
Pageof 3